© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, SELLAS Life Sciences Group, Inc. (SLS) shows an Average True Range (ATR) of 0.24 and an Enterprise Value of 84.93M. Its average trading volume over the past 3 months is 4.91M, indicating liquidity. These fundamental metrics provide insight into SLS's underlying financial health and market activity.
SELLAS Life Sciences Group, Inc. (SLS) technical indicators as of December 30, 2025: the SMA 20 is 55.27%, SMA 50 at 77.96%, and SMA 200 at 96.82%. The RSI 14 value is 86.97, suggesting its current momentum. These technical analysis signals help assess SLS's price trends and potential future movements.
SELLAS Life Sciences Group, Inc. (SLS) stock performance overview as of December 30, 2025: The 52-week high is $3.44 (currently 11.3% below), and the 52-week low is $0.851 (currently 293.89% above). Over the past year, SLS's performance is N/A, compared to the S&P 500's 10.62% change.
According to market data, SELLAS Life Sciences Group, Inc. (SLS) stock's recent performance metrics show that over the last month, SLS is 132.64%, with a Year-to-Date (YTD) performance of 222.12%. Over the past year, the stock has seen a N/A change. These figures summarize SLS's price movements across various periods, reflecting its historical returns.
According to current financial data, SLS stock's P/E (TTM) ratio is -10.77, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for SLS, including P/S (N/A), P/B (10.82), and P/FCF (-9.65), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.